FDA, Advisers Mull Framework For Waiving Pediatric Cancer Drug Studies

  • Rochelle Bagatell

Press/Media

Period17 May 2022

Media coverage

1

Media coverage

  • TitleFDA, Advisers Mull Framework For Waiving Pediatric Cancer Drug Studies
    Media name/outletInside Health Policy
    Country/TerritoryUnited States
    Date17/05/22
    PersonsRochelle Bagatell